Bio-Techne Corporation
TECH
$60.24
$1.773.02%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.20B | 1.17B | 1.16B | 1.15B | 1.14B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.20B | 1.17B | 1.16B | 1.15B | 1.14B |
| Cost of Revenue | 404.01M | 398.40M | 388.61M | 380.84M | 374.82M |
| Gross Profit | 792.00M | 773.19M | 770.45M | 773.45M | 770.18M |
| SG&A Expenses | 447.37M | 434.32M | 430.01M | 418.81M | 411.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 950.02M | 929.26M | 915.28M | 895.74M | 879.60M |
| Operating Income | 246.00M | 242.33M | 243.78M | 258.54M | 265.40M |
| Income Before Tax | 185.79M | 176.30M | 185.69M | 232.35M | 251.46M |
| Income Tax Expenses | 27.66M | 25.59M | 17.59M | 29.34M | 27.30M |
| Earnings from Continuing Operations | 158.14 | 150.71 | 168.11 | 203.00 | 224.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 0.00 | 0.00 |
| Net Income | 158.14M | 150.71M | 168.11M | 203.00M | 224.16M |
| EBIT | 246.00M | 242.33M | 243.78M | 258.54M | 265.40M |
| EBITDA | 356.59M | 353.64M | 355.49M | 369.12M | 375.64M |
| EPS Basic | 1.00 | 0.96 | 1.07 | 1.29 | 1.42 |
| Normalized Basic EPS | 0.92 | 0.90 | 0.88 | 0.94 | 0.99 |
| EPS Diluted | 1.00 | 0.95 | 1.05 | 1.25 | 1.37 |
| Normalized Diluted EPS | 0.90 | 0.89 | 0.87 | 0.92 | 0.96 |
| Average Basic Shares Outstanding | 632.14M | 631.24M | 630.84M | 630.48M | 630.48M |
| Average Diluted Shares Outstanding | 642.89M | 642.32M | 643.15M | 644.42M | 645.54M |
| Dividend Per Share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
| Payout Ratio | 32.02% | 33.48% | 29.99% | 24.82% | 22.48% |
